Aspirin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

58 Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 1 EU WC, 4 KDMF, 32 NDC API, 27 Listed Suppliers

DEVELOPMENTS

34 Drug(s) in Development

34 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

419 Dossiers, 117 FDA Orange Book, 95 Europe, 91 Canada, 9 Australia, 24 South Africa, 83 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

Suppliers, 47 Roquette, 40 Kerry, 40 BASF, 31 SPI Pharma, 24 Microlex e.U, 19 Seppic, 17 Ideal Cures Pvt Ltd, 16 Nanjing Well Pharmaceutical, 16 Gangwal Chemicals, 15 Corel Pharma Chem, 15 Gangwal Healthcare, 15 Actylis, 13 Rochem International Inc, 12 Sigachi Industries, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 DKSH, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 5 Kima Chemical, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Vasa Pharmachem, 5 Pharmatrans-Sanaq, 4 The Dow Chemical Company, 4 ACG Worldwide, 3 Ulanqab Kema New Material, 3 Clariant, 3 Finar, 3 Evonik, 3 Doshion Polyscience, 3 Jai Radhe Sales, 3 Pharm-RX Chemical, 3 Alcedo Pharmachem, 2 Zhejiang Huakang Pharmaceutical, 2 Minakem, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Aeon Procare, 2 Seqens, 2 Pfanstiehl, 2 Qualicaps, 2 Nomisma Healthcare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Vertellus, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 NEWEDGE Overseas, 1 Nanjing Bold Chemical, 1 Chynops Pharma

EXCIPIENTS BY APPLICATIONS

115 Fillers, Diluents & Binders, 88 Coating Systems & Additives, 52 Direct Compression, 52 Controlled & Modified Release, 49 Disintegrants & Superdisintegrants, 48 Solubilizers, 44 Taste Masking, 43 Thickeners and Stabilizers, 36 Granulation, 35 Parenteral, 32 Topical, 31 Film Formers & Plasticizers, 29 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 14 API Stability Enhancers, 11 Emulsifying Agents, 9 Empty Capsules, 9 Surfactant & Foaming Agents, 8 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 53 Finished Drug Prices

MARKET PLACE

50 APIs, 43 DOSSIERS // FDF

PATENTS

12 US Patents

12 US Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 1 JP Standards, 7 Other Ref. Standards

DIGITAL CONTENT

9 Data Compilation & Company Tracker #PharmaFlow, 178 News

List of EP (Ph. Eur) reference standards related to Aspirin

Aspirin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

58 Suppliers

26 USDMF

9 CEP/COS

6 JDMF

1 EU WC

4 KDMF

32 NDC API

27 Listed Suppliers

DEVELOPMENTS

34 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

419 Dossiers

117 FDA Orange Book

95 Europe

91 Canada

9 Australia

24 South Africa

83 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET;ORAL - 250MG;250MG;65MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

Suppliers

47 Roquette

40 Kerry

40 BASF

31 SPI Pharma

24 Microlex e.U

19 Seppic

17 Ideal Cures Pvt Ltd

16 Nanjing Well Pharmaceutical

16 Gangwal Chemicals

15 Corel Pharma Chem

15 Gangwal Healthcare

15 Actylis

13 Rochem International Inc

12 Sigachi Industries

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 DKSH

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Boai NKY Pharmaceuticals Ltd

7 DFE Pharma

6 Lonza Capsugel

5 Kima Chemical

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Vasa Pharmachem

5 Pharmatrans-Sanaq

4 The Dow Chemical Company

4 ACG Worldwide

3 Ulanqab Kema New Material

3 Clariant

3 Finar

3 Evonik

3 Doshion Polyscience

3 Jai Radhe Sales

3 Pharm-RX Chemical

3 Alcedo Pharmachem

2 Zhejiang Huakang Pharmaceutical

2 Minakem

2 Shijiazhuang Huaxu Pharmaceutical

2 Aeon Procare

2 Seqens

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons